Table of Contents
Chapter 1. Global Implantable Medical Devices Market Executive Summary
1.1. Global Implantable Medical Devices Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Region
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Implantable Medical Devices Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Implantable Medical Devices Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Chronic Diseases
3.1.2. Rapidly Aging Population
3.1.3. Technological Advancements in Medical Implants
3.2. Market Challenges
3.2.1. High Cost of Implantation
3.2.2. Lack of Trained Professionals
3.3. Market Opportunities
3.3.1. Increased Reimbursement Policies
Chapter 4. Global Implantable Medical Devices Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Implantable Medical Devices Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Implantable Medical Devices Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Breast Implants
5.2.2. Other Implants
5.2.3. Orthopedic Implants
5.2.4. Cardiovascular Implants
5.2.5. Intraocular Lens
5.2.6. Dental Implants
Chapter 6. Global Implantable Medical Devices Market Size & Forecasts by Region 2022-2032
6.1. North America Implantable Medical Devices Market
6.1.1. U.S. Implantable Medical Devices Market
6.1.1.1. Product breakdown size & forecasts, 2022-2032
6.1.2. Canada Implantable Medical Devices Market
6.1.2.1. Product breakdown size & forecasts, 2022-2032
6.1.3. Mexico Implantable Medical Devices Market
6.1.3.1. Product breakdown size & forecasts, 2022-2032
6.2. Europe Implantable Medical Devices Market
6.2.1. Germany Implantable Medical Devices Market
6.2.2. France Implantable Medical Devices Market
6.2.3. UK Implantable Medical Devices Market
6.2.4. Italy Implantable Medical Devices Market
6.2.5. Spain Implantable Medical Devices Market
6.2.6. Rest of Europe Implantable Medical Devices Market
6.3. Asia-Pacific Implantable Medical Devices Market
6.3.1. Japan Implantable Medical Devices Market
6.3.2. China Implantable Medical Devices Market
6.3.3. Australia Implantable Medical Devices Market
6.3.4. India Implantable Medical Devices Market
6.3.5. South Korea Implantable Medical Devices Market
6.3.6. Rest of Asia Pacific Implantable Medical Devices Market
6.4. Latin America Implantable Medical Devices Market
6.4.1. Brazil Implantable Medical Devices Market
6.4.2. Saudi Arabia Implantable Medical Devices Market
6.4.3. South Africa Implantable Medical Devices Market
6.4.4. Rest of LAMEA Implantable Medical Devices Market
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. CONMED Corporation
7.1.2. Integra LifeSciences Holdings Corporation
7.1.3. Cardinal Health, Inc.
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. CONMED Corporation
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Integra LifeSciences Holdings Corporation
7.3.3. Cardinal Health, Inc.
7.3.4. C. R. Bard, Inc.
7.3.5. LivaNova PLC
7.3.6. Abbott Laboratories
7.3.7. Johnson and Johnson
7.3.8. Biotronik SE and Co. KG
7.3.9. Globus Medical, Inc.
7.3.10. Boston Scientific Corporation
7.3.11. Hoya Corporation
7.3.12.LivaNova PLC
7.3.13. Coloplast A/S
7.3.14. NeuroMetrix, Inc.
7.3.15. Cook Medical
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes